表紙:セルベースアッセイの世界市場-機会分析および業界予測:製品別、アプリケーション別(創薬、基礎研究、吸収・分布・代謝・排泄研究、毒性予測、その他)、エンドユーザー別(2021年~2030年)
市場調査レポート
商品コード
1070544

セルベースアッセイの世界市場-機会分析および業界予測:製品別、アプリケーション別(創薬、基礎研究、吸収・分布・代謝・排泄研究、毒性予測、その他)、エンドユーザー別(2021年~2030年)

Cell-based Assay Market by Product, Application (Drug Discovery, Basic Research, Absorption, Distribution, Metabolism, & Excretion Studies, Predictive Toxicology, & Others), & End User : Global Opportunity Analysis & Industry Forecast, 2021-2030

出版日: | 発行: Allied Market Research | ページ情報: 英文 264 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
セルベースアッセイの世界市場-機会分析および業界予測:製品別、アプリケーション別(創薬、基礎研究、吸収・分布・代謝・排泄研究、毒性予測、その他)、エンドユーザー別(2021年~2030年)
出版日: 2022年03月07日
発行: Allied Market Research
ページ情報: 英文 264 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のセルベースアッセイの市場規模は、2020年の117億4,400万米ドルから2030年には263億4,800万米ドルに達し、予測期間中に8.2%のCAGRで成長すると予想されています。

創薬や薬剤開発におけるセルベースアッセイの高い需要は、市場の成長を促進すると考えられます。さらに、セルベースアッセイの技術的進歩、3Dベースのセルアッセイの利用拡大、創薬における代替品の必要性の高まりなども、市場の拡大に寄与しています。

当レポートでは、世界のセルベースアッセイ市場について調査分析し、市場情勢、市場分析、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
    • 主な成功戦略
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • バイヤー間の交渉力
  • 市場シェア分析/主要企業のポジショニング
    • 市場シェア分析/主要企業のポジショニング(2020年)
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • COVID-19影響分析

第4章 セルベースアッセイ市場:製品別

  • 市場概要
  • 市場規模と予測:製品別
  • 消耗品
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
    • 試薬
      • 市場規模と予測
    • マイクロプレート
      • 市場規模と予測
    • プローブとラベル
      • 市場規模と予測
    • アッセイキット
      • 市場規模と予測
      • レポーター遺伝子アッセイ
      • 細胞増殖アッセイ
      • セカンドメッセンジャーアッセイ
      • 細胞死アッセイ
      • その他のアッセイ
    • 細胞株
      • 市場規模と予測
      • 不死化細胞株
      • 一次細胞株
      • 幹細胞株
      • その他の細胞株
  • 装置
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • サービス
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • ソフトウェア
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別

第5章 セルベースアッセイ市場:アプリケーション別

  • 市場概要
  • 市場規模と予測:アプリケーション別
  • 創薬
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • ADME研究
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • 基礎研究
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • 予測毒性学
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • その他のアプリケーション
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別

第6章 セルベースアッセイ市場:エンドユーザー別

  • 市場概要
  • 市場規模と予測:エンドユーザー別
  • 製薬企業およびバイオテクノロジー企業
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • 学術機関および政府研究機関
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • 受託研究機関
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • その他のエンドユーザー
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別

第7章 セルベースアッセイ市場:地域別

  • 市場概要
  • 市場規模と予測:地域別
  • 北米
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • 欧州
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • アジア太平洋
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別
  • ラテンアメリカ・中東・アフリカ
    • 主要な市場動向、成長因子および機会
    • 市場規模と予測:地域別
    • 市場シェア分析:国別

第8章 セルベースアッセイ市場:地域別

  • 市場概要
  • 市場規模と予測:地域別
  • 北米
    • 主要な市場動向と機会
    • 市場規模と予測:製品別
    • 市場規模と予測:アプリケーション別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:地域別
    • 市場規模と予測:国別
    • 米国のセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • カナダのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • メキシコのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
  • 欧州
    • 主要な市場動向と機会
    • 市場規模と予測:製品別
    • 市場規模と予測:アプリケーション別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:地域別
    • 市場規模と予測:国別
    • フランスのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • ドイツのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • 英国のセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • イタリアのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • スペインのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • その他の欧州のセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
  • アジア太平洋
    • 主要な市場動向と機会
    • 市場規模と予測:製品別
    • 市場規模と予測:アプリケーション別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:地域別
    • 市場規模と予測:国別
    • 日本のセルベースのアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • 中国のセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • オーストラリアのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • インドのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • 韓国のセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • その他のアジア太平洋のセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
  • ラテンアメリカ・中東・アフリカ
    • 主要な市場動向と機会
    • 市場規模と予測:製品別
    • 市場規模と予測:アプリケーション別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:地域別
    • 市場規模と予測:国別
    • ブラジルのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • サウジアラビアのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • 南アフリカのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別
    • その他のラテンアメリカ・中東・アフリカのセルベースアッセイ市場
      • 市場規模と予測:製品別
      • 市場規模と予測:アプリケーション別
      • 市場規模と予測:エンドユーザー別
      • 市場規模と予測:地域別

第9章 企業プロファイル

  • Becton, Dickinson And Company
  • Bio-Rad Laboratories
  • Cell Signaling Technology
  • Danaher Corporation
  • General Electric Company
  • Lonza Group
  • Merck Kgaa, Darmstadt, Germany
  • PerkinElmer
  • Promega
  • Thermo Fisher Scientific, Inc.
図表

LIST OF TABLES

  • TABLE 1.GLOBAL CELL BASED ASSAY MARKET, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 2.GLOBAL CELL BASED ASSAY MARKET FOR CONSUMABLES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 3.GLOBAL CELL BASED ASSAY MARKET FOR INSTRUMENTS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 4.GLOBAL CELL BASED ASSAY MARKET FOR SERVICES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 5.GLOBAL CELL BASED ASSAY MARKET FOR SOFTWARES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 6.GLOBAL CELL BASED ASSAY MARKET, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 7.GLOBAL CELL BASED ASSAY MARKET FOR DRUG DISCOVERY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 8.GLOBAL CELL BASED ASSAY MARKET FOR ADME STUDIES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 9.GLOBAL CELL BASED ASSAY MARKET FOR BASIC RESEARCH, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10.GLOBAL CELL BASED ASSAY MARKET FOR PREDICTIVE TOXICOLOGY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 11.GLOBAL CELL BASED ASSAY MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12.GLOBAL CELL BASED ASSAY MARKET, BY END USER, 2020-2030 ($MILLION)
  • TABLE 13.GLOBAL CELL BASED ASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14.GLOBAL CELL BASED ASSAY MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2020-2030 ($MILLION)
  • TABLE 15.GLOBAL CELL BASED ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 16.GLOBAL CELL BASED ASSAY MARKET FOR OTHER END USERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 17.GLOBAL CELL BASED ASSAY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 18.GLOBAL CELL BASED ASSAY MARKET FOR NORTH AMERICA, BY REGION, 2020-2030 ($MILLION)
  • TABLE 19.GLOBAL CELL BASED ASSAY MARKET FOR EUROPE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 20.GLOBAL CELL BASED ASSAY MARKET FOR ASIA PACIFIC, BY REGION, 2020-2030 ($MILLION)
  • TABLE 21.GLOBAL CELL BASED ASSAY MARKET FOR LAMEA, BY REGION, 2020-2030 ($MILLION)
  • TABLE 22.GLOBAL CELL BASED ASSAY MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 23.NORTH AMERICA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 24.NORTH AMERICA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 25.NORTH AMERICA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 26.NORTH AMERICA CELL BASED ASSAY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 27.UNITED STATES CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 28.UNITED STATES CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 29.UNITED STATES CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 30.CANADA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 31.CANADA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 32.CANADA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 33.MEXICO CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 34.MEXICO CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 35.MEXICO CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 36.EUROPE CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 37.EUROPE CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 38.EUROPE CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 39.EUROPE CELL BASED ASSAY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 40.FRANCE CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 41.FRANCE CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 42.FRANCE CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 43.GERMANY CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 44.GERMANY CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 45.GERMANY CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 46.UNITED KINGDOM CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 47.UNITED KINGDOM CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 48.UNITED KINGDOM CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 49.ITALY CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 50.ITALY CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 51.ITALY CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 52.SPAIN CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 53.SPAIN CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 54.SPAIN CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 55.REST OF EUROPE CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 56.REST OF EUROPE CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 57.REST OF EUROPE CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 58.ASIA-PACIFIC CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 59.ASIA-PACIFIC CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 60.ASIA-PACIFIC CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 61.ASIA-PACIFIC CELL BASED ASSAY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 62.JAPAN CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 63.JAPAN CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 64.JAPAN CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 65.CHINA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 66.CHINA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 67.CHINA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 68.AUSTRALIA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 69.AUSTRALIA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 70.AUSTRALIA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 71.INDIA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 72.INDIA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 73.INDIA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 74.SOUTH KOREA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 75.SOUTH KOREA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 76.SOUTH KOREA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 77.REST OF ASIA-PACIFIC CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 78.REST OF ASIA-PACIFIC CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 79.REST OF ASIA-PACIFIC CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 80.LAMEA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 81.LAMEA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 82.LAMEA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 83.LAMEA CELL BASED ASSAY, BY REGION, 2020-2030 ($MILLION)
  • TABLE 84.BRAZIL CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 85.BRAZIL CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 86.BRAZIL CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 87.SAUDI ARABIA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 88.SAUDI ARABIA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 89.SAUDI ARABIA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 90.SOUTH AFRICA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 91.SOUTH AFRICA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 92.SOUTH AFRICA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 93.REST OF LAMEA CELL BASED ASSAY, BY PRODUCT, 2020-2030 ($MILLION)
  • TABLE 94.REST OF LAMEA CELL BASED ASSAY, BY APPLICATION, 2020-2030 ($MILLION)
  • TABLE 95.REST OF LAMEA CELL BASED ASSAY, BY END USER, 2020-2030 ($MILLION)
  • TABLE 96.BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 97.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 98.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 99.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 100.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101.BIO-RAD LABORATORIES: KEY EXECUTIVES
  • TABLE 102.BIO-RAD LABORATORIES: COMPANY SNAPSHOT
  • TABLE 103.BIO-RAD LABORATORIES: OPERATING SEGMENTS
  • TABLE 104.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 105.BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106.CELL SIGNALING TECHNOLOGY: KEY EXECUTIVES
  • TABLE 107.CELL SIGNALING TECHNOLOGY: COMPANY SNAPSHOT
  • TABLE 108.CELL SIGNALING TECHNOLOGY: OPERATING SEGMENTS
  • TABLE 109.CELL SIGNALING TECHNOLOGY: PRODUCT PORTFOLIO
  • TABLE 110.CELL SIGNALING TECHNOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111.DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 112.DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 113.DANAHER CORPORATION: OPERATING SEGMENTS
  • TABLE 114.DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115.DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116.GENERAL ELECTRIC COMPANY: KEY EXECUTIVES
  • TABLE 117.GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
  • TABLE 118.GENERAL ELECTRIC COMPANY: OPERATING SEGMENTS
  • TABLE 119.GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
  • TABLE 120.GENERAL ELECTRIC COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121.LONZA GROUP: KEY EXECUTIVES
  • TABLE 122.LONZA GROUP: COMPANY SNAPSHOT
  • TABLE 123.LONZA GROUP: OPERATING SEGMENTS
  • TABLE 124.LONZA GROUP: PRODUCT PORTFOLIO
  • TABLE 125.LONZA GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 126.MERCK KGAA, DARMSTADT, GERMANY: KEY EXECUTIVES
  • TABLE 127.MERCK KGAA, DARMSTADT, GERMANY: COMPANY SNAPSHOT
  • TABLE 128.MERCK KGAA, DARMSTADT, GERMANY: OPERATING SEGMENTS
  • TABLE 129.MERCK KGAA, DARMSTADT, GERMANY: PRODUCT PORTFOLIO
  • TABLE 130.MERCK KGAA, DARMSTADT, GERMANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 131.PERKINELMER: KEY EXECUTIVES
  • TABLE 132.PERKINELMER: COMPANY SNAPSHOT
  • TABLE 133.PERKINELMER: OPERATING SEGMENTS
  • TABLE 134.PERKINELMER: PRODUCT PORTFOLIO
  • TABLE 135.PERKINELMER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 136.PROMEGA: KEY EXECUTIVES
  • TABLE 137.PROMEGA: COMPANY SNAPSHOT
  • TABLE 138.PROMEGA: OPERATING SEGMENTS
  • TABLE 139.PROMEGA: PRODUCT PORTFOLIO
  • TABLE 140.PROMEGA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 141.THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 142.THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 143.THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
  • TABLE 144.THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 145.THERMO FISHER SCIENTIFIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

  • FIGURE 1.GLOBAL CELL BASED ASSAY MARKET SEGMENTATION
  • FIGURE 2.GLOBAL CELL BASED ASSAY MARKET
  • FIGURE 3.SEGMENTATION CELL BASED ASSAY MARKET
  • FIGURE 4.TOP INVESTMENT POCKET IN CELL BASED ASSAY MARKET
  • FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
  • FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
  • FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
  • FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 11.LOW THREAT OF SUBSTITUTION
  • FIGURE 12.HIGH COMPETITIVE RIVALRY
  • FIGURE 13.TOP PLAYER POSITIONING, 2020
  • FIGURE 14.MARKET SHARE ANALYSIS, 2020
  • FIGURE 15.RESTRAINTS AND DRIVERS: CELL BASED ASSAY MARKET
  • FIGURE 16.CELL BASED ASSAY MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 17.CELL BASED ASSAY MARKET FOR CONSUMABLES, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 18.CELL BASED ASSAY MARKET FOR INSTRUMENTS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 19.CELL BASED ASSAY MARKET FOR SERVICES, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 20.CELL BASED ASSAY MARKET FOR SOFTWARES, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 21.CELL BASED ASSAY MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 22.CELL BASED ASSAY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 23.CELL BASED ASSAY MARKET FOR ADME STUDIES, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 24.CELL BASED ASSAY MARKET FOR BASIC RESEARCH, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 25.CELL BASED ASSAY MARKET FOR PREDICTIVE TOXICOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 26.CELL BASED ASSAY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 27.CELL BASED ASSAY MARKET SEGMENTATION, BY END USER
  • FIGURE 28.CELL BASED ASSAY MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 29.CELL BASED ASSAY MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 30.CELL BASED ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 31.CELL BASED ASSAY MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 32.CELL BASED ASSAY MARKET SEGMENTATION, BY REGION
  • FIGURE 33.CELL BASED ASSAY MARKET FOR NORTH AMERICA, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 34.CELL BASED ASSAY MARKET FOR EUROPE, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 35.CELL BASED ASSAY MARKET FOR ASIA PACIFIC, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 36.CELL BASED ASSAY MARKET FOR LAMEA, BY COUNTRY, 2020-2030 ($MILLION)
  • FIGURE 37.BECTON, DICKINSON AND COMPANY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 38.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 39.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 40.BIO-RAD LABORATORIES: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 41.BIO-RAD LABORATORIES: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 42.BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 43.CELL SIGNALING TECHNOLOGY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 44.CELL SIGNALING TECHNOLOGY: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 45.CELL SIGNALING TECHNOLOGY: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 46.DANAHER CORPORATION: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 47.DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 48.DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 49.GENERAL ELECTRIC COMPANY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 50.GENERAL ELECTRIC COMPANY: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 51.GENERAL ELECTRIC COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 52.LONZA GROUP: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 53.LONZA GROUP: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 54.LONZA GROUP: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 55.MERCK KGAA, DARMSTADT, GERMANY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 56.MERCK KGAA, DARMSTADT, GERMANY: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 57.MERCK KGAA, DARMSTADT, GERMANY: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 58.PERKINELMER: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 59.PERKINELMER: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 60.PERKINELMER: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 61.PROMEGA: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 62.PROMEGA: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 63.PROMEGA: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 64.THERMO FISHER SCIENTIFIC, INC.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 65.THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 66.THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE, BY REGION, 2020 (%)
目次
Product Code: LI_174425 / A04076

The global cell-based assay market was valued $ 11,744 million in 2020 and expected to reach $26,348 million by 2030, with a CAGR of 8.2% from 2021 to 2030.

Cell-based assays are in-vitro assays that are used to examine a variety of cellular characteristics, such as cytotoxicity and cell signaling activation. Cell-based assays and analyses are viable experimental instruments in life sciences research and bio production. The method is based on cell culture procedures, in which living cells are produced in in-vitro and used as model systems for evaluating the biochemistry and physiology of both, healthy and sick cells.

The cell-based assays market is expected to rise in revenue due to technological improvements and widespread use of assays in numerous medicinal applications. Furthermore, a number of major firms are focused on tactics to develop their respective product lines and portfolios, as well as to maintain their market position. Cell-based assays are analytical methods used to investigate a cellular function mechanism or process. Consumables such as reagents, test kits, and microplates, as well as instruments, services, and software, are available from companies creating cell-based assays. Reagents, cell lines, microplates, microplates, assay kits, probes and labels, and other items are included in this report. The high cost of instruments is a major restraint on the global market for cell-based assays. Due to low adaptability, the high cost of the instruments will diminish the return on investment (ROI). Biotek, for example, created HCA (high content analysis) devices, which are costly and only available to industrial end-users or core labs with appropriate capital budgets. The high demand for cell-based tests in drug development and discovery drives the revenue growth of the market. Furthermore, technological advancements in cell-based assays, expanding usage of 3D-based cell assays, and the growing necessity for generating biologically relevant replacements for drug discovery are all contributing to market expansion.

The industry's participants are modifying their long- and short-term growth strategies to capitalize on opportunities in the research market by introducing innovative goods to combat the pandemic. For both, researchers and laboratories, the rise in need for COVID-19 research has provided a wide scope for cell-based 45 tests in viral infection research, vaccine development, and overall drug discovery. A variety of COVID-19 vaccines or antiviral medications have been approved or are in development, and patients are now being treated symptomatically. The functional efficiency of the antibodies produced to neutralize the target virus is assessed for both vaccinations and treatments. Cell-based assays are used to reduce the time and boost the throughput of these experiments.

The cell-based assay market is segmented on the basis of product, application, end user, and geography. On the basis of product, it is categorized into consumable, instrument, service, and software. The consumable segment includes reagents, microplates, probes & labels, assay kits, cell lines, and others. Assay kits are further sub-divided into reporter gene assays, cell growth assays, second messenger assays, cell death assays, and others. Likewise, the cell lines are divided into immortalized cell lines, primary cell lines, and stem cell lines. On the basis of application, the market is divided into drug discovery; basic research; absorption, distribution, metabolism, & excretion (ADME) studies; predictive toxicology; and others.

On the basis of end user, it is categorized into pharmaceutical & biotechnology companies, academic & government research institutes, contract research organizations, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the global cell-based assay market are Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Lonza Group Ltd., Cell Signaling Technology, Inc., and Promega Corporation.

The other prominent players in the value chain include Macrogen, Inc., New England Biolabs, Inc., Cisbio Bioassays, Cell Biolabs, Inc., and DiscoverX Corporation.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market

KEY MARKET SEGMENTS

  • By Product
  • Consumable
  • Reagents
  • Microplates
  • Probes & Labels
  • Assay Kits
  • Reporter Gene Assays
  • Cell Growth Assays
  • Second Messenger Assays
  • Cell Death Assays
  • Others
  • Cell Lines
  • Immortalized Cell Lines
  • Primary Cell Lines
  • Stem Cell Lines
  • Other Cell Line
  • Other Cell Line
  • Instrument
  • Service
  • Software
  • By End User
  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Research Institutes
  • Contract Research Organizations
  • Others
  • By Application
  • Drug Discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Others
  • By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Taiwan
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Share Analysis/Top Player Positioning
    • 3.4.1. Market Share Analysis/Top Player Positioning 2020
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities
  • 3.6. COVID-19 Impact Analysis

CHAPTER 4: CELL BASED ASSAY MARKET, BY PRODUCT

  • 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Consumables
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
    • 4.2.4. Reagents
      • 4.2.4.1. Market Size and Forecast
    • 4.2.5. Microplates
      • 4.2.5.1. Market Size and Forecast
    • 4.2.6. Probes and Labels
      • 4.2.6.1. Market Size and Forecast
    • 4.2.7. Assay Kits
      • 4.2.7.1. Market Size and Forecast
      • 4.2.8.2. Reporter Gene Assays
      • 4.2.8.2.1. Market Size and Forecast
      • 4.2.8.2. Cell Growth Assays
      • 4.2.8.2.1. Market Size and Forecast
      • 4.2.8.2. Second Messenger Assays
      • 4.2.8.2.1. Market Size and Forecast
      • 4.2.8.2. Cell Death Assays
      • 4.2.8.2.1. Market Size and Forecast
      • 4.2.8.2. Other Assays
      • 4.2.8.2.1. Market Size and Forecast
    • 4.2.8. Cell Lines
      • 4.2.8.1. Market Size and Forecast
      • 4.2.9.2. Immortalized Cell Line
      • 4.2.9.2.1. Market Size and Forecast
      • 4.2.9.2. Primary Cell Line
      • 4.2.9.2.1. Market Size and Forecast
      • 4.2.9.2. Stem Cell Line
      • 4.2.9.2.1. Market Size and Forecast
      • 4.2.9.2. Other Cell Line
      • 4.2.9.2.1. Market Size and Forecast
  • 4.3. Instruments
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Services
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Softwares
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country

CHAPTER 5: CELL BASED ASSAY MARKET, BY APPLICATION

  • 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Drug Discovery
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. ADME Studies
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Basic Research
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Predictive Toxicology
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Other Applications
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: CELL BASED ASSAY MARKET, BY END USER

  • 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Pharmaceutical And Biotechnology Companies
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Academic And Government Research Institutes
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Contract Research Organizations
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Other End Users
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country

CHAPTER 7: CELL BASED ASSAY MARKET, BY REGION

  • 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Europe
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Asia Pacific
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country

CHAPTER 8: CELL BASED ASSAY MARKET, BY REGION

  • 8.1. Market Overview
  • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product
    • 8.2.3. Market Size and Forecast, By Application
    • 8.2.4. Market Size and Forecast, By End User
    • 8.2.5. Market Size and Forecast, By Region
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. United States Cell Based Assay Market
      • 8.2.7.1. Market Size and Forecast, By Product
      • 8.2.7.2. Market Size and Forecast, By Application
      • 8.2.7.3. Market Size and Forecast, By End User
      • 8.2.7.4. Market Size and Forecast, By Region
    • 8.2.8. Canada Cell Based Assay Market
      • 8.2.8.1. Market Size and Forecast, By Product
      • 8.2.8.2. Market Size and Forecast, By Application
      • 8.2.8.3. Market Size and Forecast, By End User
      • 8.2.8.4. Market Size and Forecast, By Region
    • 8.2.9. Mexico Cell Based Assay Market
      • 8.2.9.1. Market Size and Forecast, By Product
      • 8.2.9.2. Market Size and Forecast, By Application
      • 8.2.9.3. Market Size and Forecast, By End User
      • 8.2.9.4. Market Size and Forecast, By Region
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product
    • 8.3.3. Market Size and Forecast, By Application
    • 8.3.4. Market Size and Forecast, By End User
    • 8.3.5. Market Size and Forecast, By Region
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Cell Based Assay Market
      • 8.3.7.1. Market Size and Forecast, By Product
      • 8.3.7.2. Market Size and Forecast, By Application
      • 8.3.7.3. Market Size and Forecast, By End User
      • 8.3.7.4. Market Size and Forecast, By Region
    • 8.3.8. Germany Cell Based Assay Market
      • 8.3.8.1. Market Size and Forecast, By Product
      • 8.3.8.2. Market Size and Forecast, By Application
      • 8.3.8.3. Market Size and Forecast, By End User
      • 8.3.8.4. Market Size and Forecast, By Region
    • 8.3.9. U.K Cell Based Assay Market
      • 8.3.9.1. Market Size and Forecast, By Product
      • 8.3.9.2. Market Size and Forecast, By Application
      • 8.3.9.3. Market Size and Forecast, By End User
      • 8.3.9.4. Market Size and Forecast, By Region
    • 8.3.10. Italy Cell Based Assay Market
      • 8.3.10.1. Market Size and Forecast, By Product
      • 8.3.10.2. Market Size and Forecast, By Application
      • 8.3.10.3. Market Size and Forecast, By End User
      • 8.3.10.4. Market Size and Forecast, By Region
    • 8.3.11. Spain Cell Based Assay Market
      • 8.3.11.1. Market Size and Forecast, By Product
      • 8.3.11.2. Market Size and Forecast, By Application
      • 8.3.11.3. Market Size and Forecast, By End User
      • 8.3.11.4. Market Size and Forecast, By Region
    • 8.3.12. Rest Of Europe Cell Based Assay Market
      • 8.3.12.1. Market Size and Forecast, By Product
      • 8.3.12.2. Market Size and Forecast, By Application
      • 8.3.12.3. Market Size and Forecast, By End User
      • 8.3.12.4. Market Size and Forecast, By Region
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product
    • 8.4.3. Market Size and Forecast, By Application
    • 8.4.4. Market Size and Forecast, By End User
    • 8.4.5. Market Size and Forecast, By Region
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. Japan Cell Based Assay Market
      • 8.4.7.1. Market Size and Forecast, By Product
      • 8.4.7.2. Market Size and Forecast, By Application
      • 8.4.7.3. Market Size and Forecast, By End User
      • 8.4.7.4. Market Size and Forecast, By Region
    • 8.4.8. China Cell Based Assay Market
      • 8.4.8.1. Market Size and Forecast, By Product
      • 8.4.8.2. Market Size and Forecast, By Application
      • 8.4.8.3. Market Size and Forecast, By End User
      • 8.4.8.4. Market Size and Forecast, By Region
    • 8.4.9. Australia Cell Based Assay Market
      • 8.4.9.1. Market Size and Forecast, By Product
      • 8.4.9.2. Market Size and Forecast, By Application
      • 8.4.9.3. Market Size and Forecast, By End User
      • 8.4.9.4. Market Size and Forecast, By Region
    • 8.4.10. India Cell Based Assay Market
      • 8.4.10.1. Market Size and Forecast, By Product
      • 8.4.10.2. Market Size and Forecast, By Application
      • 8.4.10.3. Market Size and Forecast, By End User
      • 8.4.10.4. Market Size and Forecast, By Region
    • 8.4.11. South Korea Cell Based Assay Market
      • 8.4.11.1. Market Size and Forecast, By Product
      • 8.4.11.2. Market Size and Forecast, By Application
      • 8.4.11.3. Market Size and Forecast, By End User
      • 8.4.11.4. Market Size and Forecast, By Region
    • 8.4.12. Rest Of Asia-pacific Cell Based Assay Market
      • 8.4.12.1. Market Size and Forecast, By Product
      • 8.4.12.2. Market Size and Forecast, By Application
      • 8.4.12.3. Market Size and Forecast, By End User
      • 8.4.12.4. Market Size and Forecast, By Region
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product
    • 8.5.3. Market Size and Forecast, By Application
    • 8.5.4. Market Size and Forecast, By End User
    • 8.5.5. Market Size and Forecast, By Region
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Cell Based Assay Market
      • 8.5.7.1. Market Size and Forecast, By Product
      • 8.5.7.2. Market Size and Forecast, By Application
      • 8.5.7.3. Market Size and Forecast, By End User
      • 8.5.7.4. Market Size and Forecast, By Region
    • 8.5.8. Saudi Arabia Cell Based Assay Market
      • 8.5.8.1. Market Size and Forecast, By Product
      • 8.5.8.2. Market Size and Forecast, By Application
      • 8.5.8.3. Market Size and Forecast, By End User
      • 8.5.8.4. Market Size and Forecast, By Region
    • 8.5.9. South Africa Cell Based Assay Market
      • 8.5.9.1. Market Size and Forecast, By Product
      • 8.5.9.2. Market Size and Forecast, By Application
      • 8.5.9.3. Market Size and Forecast, By End User
      • 8.5.9.4. Market Size and Forecast, By Region
    • 8.5.10. Rest of LAMEA Cell Based Assay Market
      • 8.5.10.1. Market Size and Forecast, By Product
      • 8.5.10.2. Market Size and Forecast, By Application
      • 8.5.10.3. Market Size and Forecast, By End User
      • 8.5.10.4. Market Size and Forecast, By Region

CHAPTER 9: COMPANY PROFILES

  • 9.1. Becton, Dickinson And Company
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Bio-Rad Laboratories
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Cell Signaling Technology
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Danaher Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. General Electric Company
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Lonza Group
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Merck Kgaa, Darmstadt, Germany
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. PerkinElmer
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Promega
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Thermo Fisher Scientific, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments